lithium has been researched along with ketamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 7 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Männistö, PT; Saarnivaara, L | 1 |
| Inoue, O; Itoh, T; Suhara, T; Tsukada, H; Yamasaki, T; Yonezawa, H | 1 |
| Biron, P; Latour, R | 1 |
| Rubin, EH; Wooten, GF | 1 |
| Cook, LL | 1 |
| Persinger, MA; St-Pierre, LS | 1 |
| Brody, SA; Geyer, MA; Large, CH; Ong, JC | 1 |
| Budni, J; Dal-Pizzol, F; Deroza, PF; Fraga, Dde B; Ghedim, FV; Oliveira, MB; Quevedo, J; Steckert, AV; Valvassori, SS; Zugno, AI | 1 |
| Barbas, C; Laje, G; Lorenzo, MP; Ramamoorthy, A; Silva dos Santos, M; Villaseñor, A; Wainer, IW; Zarate, C | 1 |
| Löscher, W | 1 |
| Ballard, ED; Brutsche, NE; Ionescu, DF; Luckenbaugh, DA; Lundin, NB; Machado-Vieira, R; Niciu, MJ; Richards, EM; Vande Voort, JL; Xu, AJ; Zarate, CA | 1 |
| Costemale-Lacoste, JF; Gaillard, R; Guilloux, JP | 1 |
| Campos, BC; da Costa, RO; de Aquino, PE; de Barros Viana, GS; de Vasconcelos, SM; do Vale, EM; Leal, LK; Neves, KR; Nogueira, BG; Xavier, CC | 1 |
| Luckenbaugh, DA; Niciu, MJ; Pennybaker, SJ; Zarate, CA | 1 |
| Ayala, K; Collins, L; Ettenberg, A; Fisher, MPA; Krug, JT; Mayes, MS | 1 |
| Bakker, IM; Kamphuis, J; Schoevers, RA; Smith-Apeldoorn, SY; Touw, DJ; Veraart, JKE; Visser, BAE | 1 |
| Butters, K; Frye, MA; McGee, SL; Morath, BA; Price, JB; Tye, SJ; Van De Wakker, SK; Yates, CG; Yates, NJ | 1 |
| Buoli, M; Caldiroli, A; Capellazzi, M; Capuzzi, E; Clerici, M; Colmegna, F; Dakanalis, A; Marcatili, M; Mucci, F; Tagliabue, I | 1 |
| Honyashiki, M; Inoue, T; Terao, I | 1 |
| Gao, TH; Li, T; Ma, XH; Ni, PY; Ni, RJ; Tian, Y; Wang, YY; Wei, JX; Zhao, LS | 1 |
| Endo, K; Kodama, W; Terao, I; Tsuge, T | 1 |
6 review(s) available for lithium and ketamine
| Article | Year |
|---|---|
Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Ketamine; Lithium; Phenobarbital; Pilocarpine; Rats; Seizures; Status Epilepticus | 2015 |
The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Ketamine; Lithium; Mood Disorders | 2016 |
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
Topics: Adult; Alcohol-Related Disorders; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Infusions, Intravenous; Ketamine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2017 |
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Depression; Drug Interactions; Female; Haloperidol; Humans; Ketamine; Lithium; Male; Olanzapine; Psychotropic Drugs; Risperidone; Schizophrenia; Treatment Outcome | 2021 |
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
Topics: Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Buspirone; Central Nervous System Stimulants; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium | 2021 |
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis
Topics: Adult; Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Lithium; Network Meta-Analysis | 2024 |
2 trial(s) available for lithium and ketamine
| Article | Year |
|---|---|
A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Bipolar Disorder; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Ketamine; Lithium; Lysophosphatidylcholines; Lysophospholipids; Male; Metabolome; Middle Aged; Pilot Projects; Valproic Acid; Young Adult | 2014 |
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketamine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2015 |
13 other study(ies) available for lithium and ketamine
| Article | Year |
|---|---|
Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse.
Topics: Alfaxalone Alfadolone Mixture; Anesthesia, Intravenous; Animals; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Ketamine; Lithium; Male; Methohexital; Mice; Propanidid; Rubidium; Sleep; Thiopental; Time Factors | 1976 |
Effect of lithium and anesthetics on in vivo binding of dopamine receptors.
Topics: Animals; Apomorphine; Benzazepines; Ketamine; Lithium; Male; Mice; Mice, Inbred C3H; Pentobarbital; Rats; Receptors, Dopamine; Spiperone | 1991 |
[Five new drugs offered in 1970].
Topics: Benzazepines; Carbonates; Dihydroxyphenylalanine; Flurazepam; Hypnotics and Sedatives; Ketamine; Lithium; Mesoridazine | 1972 |
Lithium-ketamine interaction: an animal study of potential clinical and theoretical interest.
Topics: Animals; Behavior, Animal; Body Weight; Drug Interactions; Ketamine; Lithium; Male; Rats; Rats, Inbred Strains | 1982 |
Ventricular enlargement and the lithium/pilocarpine seizure model: possible explanation for agonistic behaviour.
Topics: Acepromazine; Agonistic Behavior; Animals; Anticonvulsants; Ketamine; Lateral Ventricles; Lithium; Male; Pilocarpine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 2000 |
The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.
Topics: Acepromazine; Age Factors; Animals; Brain; Brain Damage, Chronic; Disease Models, Animal; Ketamine; Lithium; Male; Neurons; Pilocarpine; Rats; Rats, Wistar; Seizures | 2002 |
An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
Topics: Amphetamine; Anesthetics, Dissociative; Animals; Antimanic Agents; Carbamazepine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Ketamine; Lithium; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phenytoin; Reflex, Startle; Valproic Acid | 2005 |
Evaluation of behavioral and neurochemical changes induced by ketamine in rats: implications as an animal model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Disease Models, Animal; Drug Interactions; Ketamine; Lithium; Male; Protein Carbonylation; Rats; Rats, Wistar; Valproic Acid | 2012 |
Antinociceptive and Anti-Inflammatory Effects of Ketamine and the Relationship to Its Antidepressant Action and GSK3 Inhibition.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Behavior, Animal; Cyclooxygenase 2; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Glycogen Synthase Kinase 3 beta; Immunohistochemistry; Ketamine; Lithium; Male; Mice; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Receptors, N-Methyl-D-Aspartate; Subcutaneous Tissue; Tumor Necrosis Factor-alpha | 2016 |
Differential effects of lithium isotopes in a ketamine-induced hyperactivity model of mania.
Topics: Animals; Antimanic Agents; Behavior, Animal; Disease Models, Animal; Isotopes; Ketamine; Lithium; Lithium Chloride; Locomotion; Male; Mania; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2020 |
Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression.
Topics: Adaptation, Psychological; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder, Treatment-Resistant; Insulin; Ketamine; Lithium; Male; Rats; Rats, Wistar; Rodentia | 2021 |
A letter to the editor, associated with the article entitled "Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium" by Vázquez et al. (
Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Ketamine; Lithium; Psychopharmacology | 2022 |
Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Ketamine; Lithium; Lithium Compounds; Male; Mammals; Mania; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Rodent Diseases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2022 |